Cargando…
Intensive Care Unit Admission after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. Is It Necessary?
Introduction. Cytoreductive surgery (CS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a new approach for peritoneal carcinomatosis. However, high rates of complications are associated with CS and HIPEC due to treatment complexity; that is why some patients need stabilization and surveil...
Autores principales: | López-Basave, Horacio N., Morales-Vasquez, Flavia, Mendez-Herrera, Carmen, Ñamendys-Silva, Silvio A., Luna-Ortiz, Kuauhyama, Calderillo-Ruiz, German, Cabrera Rojas, Jesús, Ruiz-Garcia, Erika, Herrera-Gomez, Angel, Ruiz-Molina, Juan M., Meneses Garcia, Abelardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016883/ https://www.ncbi.nlm.nih.gov/pubmed/24864143 http://dx.doi.org/10.1155/2014/307317 |
Ejemplares similares
-
Organ dysfunction in critically ill cancer patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy
por: ÑAMENDYS-SILVA, SILVIO A., et al.
Publicado: (2015) -
Morbidity and Mortality of Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: National Cancer Institute, Mexico City, Mexico
por: López-Basave, Horacio N., et al.
Publicado: (2011) -
Gastric cancer in young people under 30 years of age: worse prognosis, or delay in diagnosis?
por: López-Basave, Horacio Noé, et al.
Publicado: (2013) -
Latin American young patients with gastric adenocarcinoma: worst prognosis and outcomes
por: Calderillo-Ruíz, Germán, et al.
Publicado: (2023) -
Cytoreduction with hyperthermic intraperitoneal chemotherapy: An anaesthetic challenge
por: Murughan, Kavita, et al.
Publicado: (2014)